FDA CONFIDENTIALITY CONCERNS PRECLUDE RESPONSES TO INDIVIDUAL PATIENT COMPLAINTS ABOUT DIFFICULTIES RECEIVING UNAPPROVED MEDICATIONS, HHS MAINTAINS